Global Blood Plasma Fractionation Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Blood Plasma Fractionation Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Human blood plasma is nature"s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation.

According to our (Global Info Research) latest study, the global Blood Plasma Fractionation market size was valued at US$ 31210 million in 2023 and is forecast to a readjusted size of USD 51340 million by 2030 with a CAGR of 7.5% during review period.

Global key blood plasma fractionation players include CSL, Grifols and Takeda etc. The top 3 companies hold a share about 55%. North America is the largest market with a share about 40%, followed by Asia-Pacific and Europe.

In terms of product, Immune Globulin is the largest segment with a share about 50%. And in terms of applications, the largest application is hospital with a share about 70%.

This report is a detailed and comprehensive analysis for global Blood Plasma Fractionation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Blood Plasma Fractionation market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Blood Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Blood Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Blood Plasma Fractionation market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Blood Plasma Fractionation

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Blood Plasma Fractionation market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Blood Plasma Fractionation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other

Market segment by Application
Hospital
Retail Pharmacy
Other

Major players covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Blood Plasma Fractionation, with price, sales quantity, revenue, and global market share of Blood Plasma Fractionation from 2019 to 2024.

Chapter 3, the Blood Plasma Fractionation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Blood Plasma Fractionation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Blood Plasma Fractionation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Plasma Fractionation.

Chapter 14 and 15, to describe Blood Plasma Fractionation sales channel, distributors, customers, research findings and conclusion.